Skip to content
Genialis Logo Genialis Logo Genialis Logo
  • Solutions
    • Therapeutic Intelligence & Biomarker Discovery
    • Genialis™ krasID
    • Genialis™ Expressions
  • Approach
    • Genialis™ Supermodel
    • Genialis ResponderID™
    • Why RNA?
  • Case Studies
  • About Us
    • Meet Our Team
    • Careers
    • Compliance
  • Media
    • News and Events
    • Scientific Publications
    • Press Releases
    • TPM Podcast
  • Get in Touch
  • Solutions
    • Therapeutic Intelligence & Biomarker Discovery
    • Genialis™ krasID
    • Genialis™ Expressions
  • Approach
    • Genialis™ Supermodel
    • Genialis ResponderID™
    • Why RNA?
  • Case Studies
  • About Us
    • Meet Our Team
    • Careers
    • Compliance
  • Media
    • News and Events
    • Scientific Publications
    • Press Releases
    • TPM Podcast
  • Get in Touch

Talking Precision Medicine Podcast

Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.

Open Media Kit
  • Talking Precision Medicine podcast Episode 45. On a mission to beat an ignoble killer: pancreatic cancer, guests: Anna Berkenblit & Sudheer Doss, PanCAN
    April 22, 2025

    On a mission to beat an ignoble killer: pancreatic cancer | TPM podcast #45

  • Talking Precision Medicine podcast Episode 44. Radical Transformation: Becoming a Medicines Company with End-to-End AI, guest: Najat Khan, Chief R&D Officer and Chief Commercial Officer of Recursion
    March 28, 2025

    Radical Transformation: Becoming a Medicines Company with End-to-End AI | TPM podcast #44

  • Talking Precision Medicine podcast Episode 43. Reinventing diagnostics: The superpower of not knowing what can’t be done, guest: Ryan Fukushima, COO of Tempus AI / CEO of Pathos
    February 26, 2025

    Reinventing diagnostics: The superpower of not knowing what can’t be done | TPM podcast #43

  • Talking Precision Medicine podcast Episode 42. The View from 30,000: The journey to the top of life sciences technology: a lifetime of listening and learning, guest: Joydeep Goswami, president and CEO of LGC
    January 31, 2025

    The journey to the top of life sciences technology: a lifetime of listening and learning | TPM podcast #42

  • Talking Precision Medicine podcast Episode 41. The View from 30,000: Healthcare & Life Science AI in the Cloud, guest: Shweta Maniar, Global Director of Healthcare & Life Sciences at Google cloud
    December 18, 2024

    The view from 30,000: Healthcare & life science AI in the cloud | TPM podcast #41

  • Talking Precision Medicine podcast Episode 40. What’s in a digital twin? Inventing new kinds of AI for biomedicine, guest: Charles Fisher, co-founder and Chief Scientific Officer of Unlearn.AI
    November 15, 2024

    What’s in a digital twin? Inventing new kinds of AI for biomedicine | TPM podcast #40

  • Talking Precision Medicine podcast Episode 39. Leave No Patient Behind—R&D Tools and Cutting Edge Diagnostics that Span the Globe, guest: Thierry Bernard, CEO of Qiagen
    October 8, 2024

    Leave No Patient Behind—R&D Tools and Cutting Edge Diagnostics that Span the Globe | TPM podcast #39

  • Talking Precision Medicine podcast Episode 38. Zola-007: Giving T-cells the license to kill, guest: Art Krieg, Zola Therapeutics
    August 29, 2024

    Zola-007: Giving T-cells the license to kill | TPM podcast #38

  • Talking Precision Medicine podcast Episode 37. Cell therapy for T-cell malignancies—the science and business of developing curative medicines for patients in need, guest: Sarah Hein, March Biosciences
    July 22, 2024

    Cell therapy for T-cell malignancies—the science and business of developing curative medicines for patients in need | TPM podcast #37

12345Next

Genialis, Inc.

68 Harrison Ave #605
PMB 29417
Boston, MA 02111

Get in touch

+1 617 237 0085 (US)
+386 59 054 580 (Slo)
info @ genialis.com
biomarkers @ genialis.com
Genialis LinkedIn

Site map

  • Therapeutic Intelligence & Biomarker Discovery
  • Genialis™ krasID
  • Genialis™ Expressions
  • Why RNA
  • Genialis ResponderID™
  • Genialis™ Supermodel
  • Case Studies
  • Meet Our Team
  • Careers
  • Compliance

Media

  • News and Events
  • Scientific Publications
  • Press Releases
  • Talking Precision Medicine Podcast
Subscribe to our newsletter

Genialis is a founding member of the Alliance for AI in Healthcare

Alliance for Artificial Intelligence in Healthcare AAIH logo
  • Privacy Policy
  • Terms of Service
  • Genialis d.o.o.
  • Privacy Policy
  • Terms of Service
  • Genialis d.o.o.

Copyright © Genialis, Inc.

Page load link

Media Kit

Boilerplate

Genialis, the RNA biomarker company, is creating a world where healthcare delivers the best possible outcomes for patients, their families, and their communities. Genialis develops and validates clinically actionable biomarkers informed by the world’s most ethnographically diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Genialis is trusted by pharma and diagnostics partners, and together, we are revolutionizing precision oncology with RNA and AI.

Links & Downloads

Genialis Logo
Leadership Headshots
Talking Precision Medicine Info Sheet
Leadership Team
linkedin.com/company/genialis

Media Contact

Andrea Vuturo
Vuturo Group for Genialis
andrea@vuturo.com
+1-415-689-8414

Genialis Highlights Power of its Supermodel to Predict and Explain Therapeutic Response at AACR 2025.  Read the press release →               

Genialis Highlights Power of its Supermodel to Predict and Explain Therapeutic Response at AACR 2025.  Read the press release →               Genialis Highlights Power of its Supermodel to Predict and Explain Therapeutic Response at AACR 2025.  Read the press release →               

Subscribe to Genialis updates and information

Thanks for subscribing!
There was an error trying to subscribe. Please try again later.
This website uses cookies and third party services. Read More Accept Reject